What are the major opportunities in the Gastroparesis market? What are the strategies for the Gastroparesis market?

For detailed insights on the major opportunities and strategies in the Gastroparesis market, Read More

How does the Gastroparesis market relate to the overall economy and other similar markets?

For detailed insights on Gastroparesis's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Gastroparesis market growth? SWOT analysis of the Gastroparesis market.

For detailed insights on the key dynamics influencing the Gastroparesis market growth and SWOT analysis of the Gastroparesis industry, Read More

Gastroparesis Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Gastroparesis Market Report 2026

Name: Gastroparesis Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Treatment Modality (Medications, Dietary Modifications, Medical Devices, Other Therapies), By Gastroparesis Type (Idiopathic, Diabetic, Post- Surgical, Other Types), By Patient Demographics (Pediatric Gastroparesis, Adult Gastroparesis), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels), By End User (Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Gastroparesis Market Overview

• Gastroparesis market size has reached to $7.15 billion in 2025

• Expected to grow to $9.29 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%

• Growth Driver: Gastroparesis Market Acceleration Amidst Diabetes Trends

• Market Trend: Transformative Drugs For Gastroparesis Management

• North America was the largest region in 2025.

What Is Covered Under Gastroparesis Market?

Gastroparesis is a medical condition characterized by the impairment or weakening of the stomach muscles, resulting in delayed emptying of stomach contents into the small intestine. Gastroparesis is treated by medications to stimulate stomach emptying and manage underlying conditions, and surgical interventions.

The main treatment modalities of gastroparesis are medications, dietary modifications, medical devices, and others. Medications are substances that work by interacting with the body's biological processes to produce a desired effect. Medications such as prokinetic drugs, antiemetics, botulinum toxin injections, antidepressants, and others are used to diagnose, treat, cure, or prevent gastroparesis. These are used for the treatment of idiopathic, diabetic, post-surgical, and others in pediatric and adult patients. These are distributed by retail pharmacies, hospital pharmacies, and others, which are used by hospitals and clinics, ambulatory surgical centers, and home care settings.

Gastroparesis Market Global Report 2026 Market Report bar graph

What Is The Gastroparesis Market Size and Share 2026?

The gastroparesis market size has grown strongly in recent years. It will grow from $7.15 billion in 2025 to $7.52 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to diabetes-related gastric disorders, use of antiemetic medications, hospital-based gi care, dietary management approaches, availability of diagnostic imaging.

What Is The Gastroparesis Market Growth Forecast?

The gastroparesis market size is expected to see strong growth in the next few years. It will grow to $9.29 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to innovation in implantable stimulation devices, growth in outpatient treatment models, rising diabetic population, demand for symptom-focused therapies, improved clinical awareness. Major trends in the forecast period include increased use of prokinetic medications, growing adoption of gastric electrical stimulation devices, rising focus on dietary and lifestyle management, expansion of minimally invasive surgical options, improved diagnosis of diabetic gastroparesis.

Book your 30 minutes free consultation with our research experts

Global Gastroparesis Market Segmentation

1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies

2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types

3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis

4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Medications: Prokinetic Agents, Antiemetic Medications, Pain Management Medications

2) By Dietary Modifications: Low-Fiber Diets, Small, Frequent Meals, Pureed Or Liquid Diets

3) By Medical Devices: Gastric Electrical Stimulation Devices, Enteral Feeding Tubes

4) By Other Therapies: Acupuncture, Behavioral Therapies, Nutritional Supplements

What Is The Driver Of The Gastroparesis Market?

The rapid surge in the prevalence of diabetes is expected to propel the growth of the gastroparesis market going forward. Diabetes is a chronic medical condition characterized by elevated levels of blood glucose resulting from the body's inability to produce enough insulin or effectively use the insulin it produces. The prevalence of diabetes significantly increases the likelihood of developing gastroparesis, as diabetes plays a pivotal role in expanding the population at risk for this condition. For instance, in April 2025, according to the International Diabetes Federation, a Belgium-based advocacy organization, reported that globally, nearly one in nine adults (589 million) are now living with diabetes. Of these, an estimated 252 million are not yet aware they have the condition, placing them at higher risk of serious complications and early death. Therefore, a rapid surge in the prevalence of diabetes is driving the gastroparesis industry.

Key Players In The Global Gastroparesis Market

Major companies operating in the gastroparesis market are Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. ltd, ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., RedHill Biopharma Ltd., CinRx Pharma LLC, Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

Global Gastroparesis Market Trends and Insights

Major companies operating in gastroparesis market are developing drugs to increase their profitability in the market. Drugs used in the treatment of gastroparesis serve various purposes to address the symptoms associated with delayed stomach emptying. For instance, in December 2023, Vanda Pharmaceuticals Inc., a US-based, Biopharmaceutical Company, has reported that the U.S. FDA has accepted the New Drug Application for Tradipitant, a promising development in its potential approval for treating gastroparesis. The FDA has scheduled the decision date for Tradipitant under the Prescription Drug User Fee Act (PDUFA) on September 18, 2024. If successful, Tradipitant would mark the first FDA-approved novel drug for gastroparesis in over 40 years, representing a significant milestone in more than three decades for a drug to undergo FDA review specifically for gastroparesis.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Gastroparesis Market?

In May 2025, Dr. Falk Pharma, a Germany-based specialty pharmaceutical company focused on gastroenterology, partnered with Renexxion, to advance the development and commercialization of innovative gastrointestinal therapies. With this partnership, Dr. Falk Pharma and Renexxion aim to advance the clinical development and global commercialization of naronapride, a precision therapy for gastroparesis, combining regulatory expertise with novel prokinetic technology. Renexxion is a U.S.-based clinical-stage biotech focused on developing naronapride, a selective 5-HT4 agonist designed to improve gastric motility in patients with gastroparesis.

Regional Outlook

North America was the largest region in the gastroparesis market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastroparesis Market?

The gastroparesis market consists of sales of metoclopramide, domperidone, and erythromycin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gastroparesis Market Report 2026?

The gastroparesis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gastroparesis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Gastroparesis Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$7.52 billion
Revenue Forecast In 2035	$9.29 billion
Growth Rate	CAGR of 5.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Treatment Modality, Gastroparesis Type, Patient Demographics, Distribution Channel, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. ltd, ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., RedHill Biopharma Ltd., CinRx Pharma LLC, Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Gastroparesis Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Gastroparesis Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Gastroparesis Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Gastroparesis Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increased Use Of Prokinetic Medications

4.2.2 Growing Adoption Of Gastric Electrical Stimulation Devices

4.2.3 Rising Focus On Dietary And Lifestyle Management

4.2.4 Expansion Of Minimally Invasive Surgical Options

4.2.5 Improved Diagnosis Of Diabetic Gastroparesis

5. Gastroparesis Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Ambulatory Surgical Centers

5.4 Homecare Settings

5.5 Diagnostic Centers

6. Gastroparesis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gastroparesis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Gastroparesis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Gastroparesis Market Size, Comparisons And Growth Rate Analysis

7.3. Global Gastroparesis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Gastroparesis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gastroparesis Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gastroparesis Market Segmentation

9.1. Global Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Medications, Dietary Modifications, Medical Devices, Other Therapies

9.2. Global Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Idiopathic, Diabetic, Post- Surgical, Other Types

9.3. Global Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric Gastroparesis, Adult Gastroparesis

9.4. Global Gastroparesis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

9.5. Global Gastroparesis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings

9.6. Global Gastroparesis Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prokinetic Agents, Antiemetic Medications, Pain Management Medications

9.7. Global Gastroparesis Market, Sub-Segmentation Of Dietary Modifications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Low-Fiber Diets, Small, Frequent Meals, Pureed Or Liquid Diets

9.8. Global Gastroparesis Market, Sub-Segmentation Of Medical Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Gastric Electrical Stimulation Devices, Enteral Feeding Tubes

9.9. Global Gastroparesis Market, Sub-Segmentation Of Other Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Acupuncture, Behavioral Therapies, Nutritional Supplements

10. Gastroparesis Market Regional And Country Analysis

10.1. Global Gastroparesis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Gastroparesis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gastroparesis Market

11.1. Asia-Pacific Gastroparesis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gastroparesis Market

12.1. China Gastroparesis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gastroparesis Market

13.1. India Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gastroparesis Market

14.1. Japan Gastroparesis Market Overview

14.2. Japan Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gastroparesis Market

15.1. Australia Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gastroparesis Market

16.1. Indonesia Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gastroparesis Market

17.1. South Korea Gastroparesis Market Overview

17.2. South Korea Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gastroparesis Market

18.1. Taiwan Gastroparesis Market Overview

18.2. Taiwan Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gastroparesis Market

19.1. South East Asia Gastroparesis Market Overview

19.2. South East Asia Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gastroparesis Market

20.1. Western Europe Gastroparesis Market Overview

20.2. Western Europe Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gastroparesis Market

21.1. UK Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gastroparesis Market

22.1. Germany Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gastroparesis Market

23.1. France Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gastroparesis Market

24.1. Italy Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gastroparesis Market

25.1. Spain Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gastroparesis Market

26.1. Eastern Europe Gastroparesis Market Overview

26.2. Eastern Europe Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gastroparesis Market

27.1. Russia Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gastroparesis Market

28.1. North America Gastroparesis Market Overview

28.2. North America Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gastroparesis Market

29.1. USA Gastroparesis Market Overview

29.2. USA Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gastroparesis Market

30.1. Canada Gastroparesis Market Overview

30.2. Canada Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gastroparesis Market

31.1. South America Gastroparesis Market Overview

31.2. South America Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gastroparesis Market

32.1. Brazil Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gastroparesis Market

33.1. Middle East Gastroparesis Market Overview

33.2. Middle East Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gastroparesis Market

34.1. Africa Gastroparesis Market Overview

34.2. Africa Gastroparesis Market, Segmentation By Treatment Modality, Segmentation By Gastroparesis Type, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gastroparesis Market Regulatory and Investment Landscape

36. Gastroparesis Market Competitive Landscape And Company Profiles

36.1. Gastroparesis Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Gastroparesis Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Gastroparesis Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AstraZeneca Plc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Medtronic Plc. Overview, Products and Services, Strategy and Financial Analysis

37. Gastroparesis Market Other Major And Innovative Companies

Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. ltd, ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., RedHill Biopharma Ltd., CinRx Pharma LLC, Ritter Pharmaceuticals Inc., Evoke Pharma Inc.

38. Global Gastroparesis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gastroparesis Market

40. Gastroparesis Market High Potential Countries, Segments and Strategies

40.1 Gastroparesis Market In 2030 - Countries Offering Most New Opportunities

40.2 Gastroparesis Market In 2030 - Segments Offering Most New Opportunities

40.3 Gastroparesis Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Gastroparesis Market, Overview Of Key Products - Product Examples

Table 2: Global Gastroparesis Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Gastroparesis Market, Supply Chain Analysis

Table 4: Global Gastroparesis Market, Major Raw Material Providers

Table 5: Global Gastroparesis Market, Major Resource Providers

Table 6: Global Gastroparesis Market, Major Manufacturers (Suppliers)

Table 7: Global Gastroparesis Market, Major Distributors And Channel Partners

Table 8: Global Gastroparesis Market, Key Technologies & Future Trends

Table 9: Global Gastroparesis Market, Major Trends

Table 10: Global Gastroparesis Market, Major End Users

Table 11: Global Gastroparesis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Gastroparesis Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Gastroparesis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Gastroparesis Market - TAM, US$ Billion, 2025

Table 15: Global Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Gastroparesis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Gastroparesis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Gastroparesis Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Gastroparesis Market, Sub-Segmentation Of Dietary Modifications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Gastroparesis Market, Sub-Segmentation Of Medical Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Gastroparesis Market, Sub-Segmentation Of Other Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Gastroparesis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Gastroparesis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Gastroparesis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Gastroparesis Market - Company Scoring Matrix

Table 100: Pfizer Inc. Financial Performance

Table 101: GlaxoSmithKline plc. Financial Performance

Table 102: Abbott Laboratories Inc. Financial Performance

Table 103: AstraZeneca Plc. Financial Performance

Table 104: Medtronic Plc. Financial Performance

Table 105: Global Gastroparesis Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Gastroparesis Market, Competitive Dashboard

Table 107: Global Gastroparesis Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Gastroparesis Market Size Gain ($ Billion), Segmentation By Treatment Modality, 2025 – 2030

Table 109: Global, Gastroparesis Market Size Gain ($ Billion), Segmentation By Gastroparesis Type, 2025 – 2030

Table 110: Global, Gastroparesis Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

List Of Figures

Figure 1: Global Gastroparesis Market, Overview Of Key Products - Product Examples

Figure 2: Global Gastroparesis Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Gastroparesis Market, Supply Chain Analysis

Figure 4: Global Gastroparesis Market, Major Raw Material Providers

Figure 5: Global Gastroparesis Market, Major Resource Providers

Figure 6: Global Gastroparesis Market, Major Manufacturers (Suppliers)

Figure 7: Global Gastroparesis Market, Major Distributors And Channel Partners

Figure 8: Global Gastroparesis Market, Key Technologies & Future Trends

Figure 9: Global Gastroparesis Market, Major Trends

Figure 10: Global Gastroparesis Market, Major End Users

Figure 11: Global Gastroparesis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Gastroparesis Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Gastroparesis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Gastroparesis Market - TAM, US$ Billion, 2025

Figure 15: Global Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Gastroparesis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Gastroparesis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Gastroparesis Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Gastroparesis Market, Sub-Segmentation Of Dietary Modifications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Gastroparesis Market, Sub-Segmentation Of Medical Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Gastroparesis Market, Sub-Segmentation Of Other Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Gastroparesis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Gastroparesis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Gastroparesis Market, Segmentation By Treatment Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Gastroparesis Market, Segmentation By Gastroparesis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Gastroparesis Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Gastroparesis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Gastroparesis Market - Company Scoring Matrix

Figure 100: Pfizer Inc. Financial Performance

Figure 101: GlaxoSmithKline plc. Financial Performance

Figure 102: Abbott Laboratories Inc. Financial Performance

Figure 103: AstraZeneca Plc. Financial Performance

Figure 104: Medtronic Plc. Financial Performance

Figure 105: Global Gastroparesis Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Gastroparesis Market, Competitive Dashboard

Figure 107: Global Gastroparesis Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Gastroparesis Market Size Gain ($ Billion), Segmentation By Treatment Modality, 2025 – 2030

Figure 109: Global, Gastroparesis Market Size Gain ($ Billion), Segmentation By Gastroparesis Type, 2025 – 2030

Figure 110: Global, Gastroparesis Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

Global Outpatient Clinics Market Forecast to Reach $53.81 Billion by 2029, Driven by 5.3% CAGR

Outpatient Home Therapy Industry Poised for Rapid Expansion, Projected to Hit $72.97 Billion by 2029

In-Depth Outpatient Oncology Infusion Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Outpatient Rehabilitation Services Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Food Grade Gases Market Report 2026 - Global Outlook – By Type (Carbon Di Oxide, Nitrogen, Oxygen, Sulfur Dioxide, Other Types ), By Application (Freezing And Chilling, Packaging, Carbonation, Other Applications), By End...

Dental Flap Surgery Market Report 2026 - Global Outlook – By Flap Type (Trapezoidal Flap, Triangular Flap, Envelope Flap, Semilunar Flap, Pedicle Flap), By Incision Type (Horizontal, Vertical), By Technique (Modified Wid...

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Report 2026 - Global Outlook – By Type (Capping Agents, Nucleotides, Plasmid DNA, Other Types), By Applications (Therapeutics Production, Vaccine Productio...

Viral Vector Manufacturing Market Report 2026 - Global Outlook – By Type (Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types), By Disease (Cancer, Genetic Disorders, I...

Veterinary Orthopedic Medicine Market Report 2026 - Global Outlook – By Product (Biologics, Viscosupplements, Pharmaceuticals), By Animal Type (Canine, Feline, Equine, Cattle, Swine, Other Animal Types), By Application (...

Frequently Asked Questions

How big is the Gastroparesis Market?

The Gastroparesis market was valued at $7.15 billion in 2025, increased to $7.52 billion in 2026, and is projected to reach $9.29 billion by 2030.

What is the Gastroparesis market growth?

The global Gastroparesis market is expected to grow at a CAGR of 5.5% from 2026 to 2035 to reach $9.29 billion by 2035.

Who are the key players in Gastroparesis market?

Some Key Players in the Gastroparesis market Include, Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industri

Major trend in this market includes: Transformative Drugs For Gastroparesis Management. For further insights on this market. request a sample here

North America was the largest region in the gastroparesis market in 2025. The regions covered in the gastroparesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Book your 30 minutes free consultation with our research experts

Contact Us